AAAAAA
Results:
1-17
|
Results: 17
Authors:
CHOI D
PERRIN M
HOFFMANN S
CHANG AE
RATANATHARATHORN V
UBERTI J
MCDONAGH KT
MULE JJ
Citation: D. Choi et al., DENDRITIC CELL-BASED VACCINES IN THE SETTING OF PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - CD34(-DEPLETED MOBILIZED PERIPHERAL-BLOOD CAN SERVE AS A SOURCE OF POTENT DENDRITIC CELLS() CELL), Clinical cancer research, 4(11), 1998, pp. 2709-2716
Authors:
JACOBSON P
UBERTI J
DAVIS W
RATANATHARATHORN V
Citation: P. Jacobson et al., TACROLIMUS - A NEW AGENT FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 22(3), 1998, pp. 217-225
Authors:
VARTERASIAN M
JANAKIRAMAN N
KARANES C
ABELLA E
UBERTI J
DRAGOVIC J
RAMAN SBK
ALKATIB A
DU W
SILVER SM
ADAMS PT
SENSENBRENNER L
RATANATHARATHORN V
Citation: M. Varterasian et al., TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA - A MULTICENTER COMPARATIVE-ANALYSIS OF PERIPHERAL-BLOOD STEM-CELL AND ALLOGENEIC TRANSPLANT, American journal of clinical oncology, 20(5), 1997, pp. 462-466
Authors:
CHOI D
WALSH M
HOFFMANN S
RATANATHARATHORN V
UBERTI J
CHANG A
MCDONAGH KT
MULE JJ
Citation: D. Choi et al., DENDRITIC CELL-BASED VACCINES IN THE SETTING OF PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - CD34-DEPLETED MOBILIZED PERIPHERAL-BLOOD CAN SERVE AS A SOURCE OF POTENT DENDRITIC CELLS( CELL), Blood, 90(10), 1997, pp. 2399-2399
Authors:
REDMAN BG
CHOU TH
ZALUPSKI M
UBERTI J
FLAHERTY L
DAN M
SENSENBRENNER L
Citation: Bg. Redman et al., PHASE-I TRIAL OF SEQUENTIAL CYCLOPHOSPHAMIDE, CYCLOSPORINE-A, AND INTERFERON-ALPHA IN PATIENTS WITH CANCER - ATTEMPT TO INDUCE AUTOLOGOUS GRAFT-VERSUS-HOST REACTION TO ELICIT AN ANTITUMOR RESPONSE, Journal of immunotherapy with emphasis on tumor immunology, 18(2), 1995, pp. 115-118
Authors:
SHEARER C
CHANDRASEKAR PH
SENSENBRENNER L
RATANATHARATHORN V
KARANES C
MOMIN F
ABELLA S
LUM L
UBERTI J
Citation: C. Shearer et al., PULMONARY NOCARDIOSIS IN A PATIENT WITH A BONE-MARROW TRANSPLANT, Bone marrow transplantation, 15(3), 1995, pp. 479-481
Authors:
VARTERASIAN M
RATANATHARATHORN V
KARANES C
UBERTI J
MOMIN F
ABELLA E
LUM LG
HEILBRUN LK
SENSENBRENNER LL
Citation: M. Varterasian et al., BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA - THE WAYNE-STATE EXPERIENCE, Bone marrow transplantation, 15(2), 1995, pp. 328-329
Authors:
MOHAMED AN
EBRAHIM SAD
SARKAR FH
UBERTI J
WOLMAN SR
Citation: An. Mohamed et al., DETECTION OF M-BCR ABL FUSION BY FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IN A CASE OF PH-NEGATIVE CML/, Cancer genetics and cytogenetics, 80(1), 1995, pp. 60-62
Authors:
CHANDRASEKAR PH
GATNY CM
SENSENBRENNER L
RATANATHARATHORN V
LUM L
KARANES C
UBERTI J
DEPLANQUE M
SCHULTZ K
Citation: Ph. Chandrasekar et al., THE EFFECT OF FLUCONAZOLE PROPHYLAXIS ON FUNGAL COLONIZATION IN NEUTROPENIC CANCER-PATIENTS, Journal of antimicrobial chemotherapy, 33(2), 1994, pp. 309-318
Authors:
LUM L
BITONTI O
JIN NR
GALOFORO S
WALKER A
LUM C
ABELLA E
BABINGTON R
KARANES C
MOMIN F
UBERTI J
RATANATHARATHORN V
SENSENBRENNER L
Citation: L. Lum et al., INTRAVENOUS GAMMA-GLOBULIN (IVIG) DOES NOT ALTER IMMUNE PARAMETERS INA RANDOMIZED TRIAL AFTER BONE-MARROW TRANSPLANTATION (BMT), Experimental hematology, 22(8), 1994, pp. 680-680
Authors:
MOMIN F
RATNATHARATHORN V
UBERTI J
ABELLA E
KARANES C
CASE P
LUM L
SENSENBRENNER L
Citation: F. Momin et al., COMPARISON OF OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)USING HLA IDENTICAL SIBLING, MATCHED UNRELATED, AND RELATED HLA MISMATCHED DONORS, Experimental hematology, 22(8), 1994, pp. 715-715
Authors:
ALANGADEN G
CHANDRASEKAR PH
BAILEY E
KHALIQ Y
SENSENBRENNER L
RATANATHARATHORN V
KARANES C
DEPLANQUE M
UBERTI J
LUM L
Citation: G. Alangaden et al., ANTIFUNGAL PROPHYLAXIS WITH LOW-DOSE FLUCONAZOLE DURING BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 14(6), 1994, pp. 919-924
Authors:
RATANATHARATHORN V
UBERTI J
KARANES C
LUM LG
ABELLA E
DAN ME
HUSSEIN M
SENSENBRENNER LL
Citation: V. Ratanatharathorn et al., PHASE-I STUDY OF ALPHA-INTERFERON AUGMENTATION OF CYCLOSPORINE-INDUCED GRAFT-VERSUS-HOST DISEASE IN RECIPIENTS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 13(5), 1994, pp. 625-630
Authors:
RATANATHARATHORN V
UBERTI J
KARANES C
ABELLA E
LUM LG
MOMIN F
CUMMINGS G
SENSENBRENNER LL
Citation: V. Ratanatharathorn et al., PROSPECTIVE COMPARATIVE TRIAL OF AUTOLOGOUS VERSUS ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Blood, 84(4), 1994, pp. 1050-1055
Authors:
RATANATHARATHORN V
KARANES C
UBERTI J
ABELLA E
LUM L
SENSENBRENNER L
Citation: V. Ratanatharathorn et al., PROSPECTIVE COMPARATIVE TRIAL OF ALLOGENEIC VS AUTOLOGOUS BONE-MARROWTRANSPLANTATION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Experimental hematology, 21(8), 1993, pp. 1112-1112
Authors:
CHERUKU R
UBERTI J
MARTILOTTI F
KAPLAN J
Citation: R. Cheruku et al., GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELLS WITH VETO AND NATURALSUPPRESSOR ACTIVITY FROM PATIENTS WITH LEUKEMIAS AND LYMPHOMAS, Transplantation, 56(4), 1993, pp. 1037-1040
Authors:
RATANATHARATHORN V
KARANES C
UBERTI J
LUM LG
DEPLANQUE MM
SCHULTZ KR
CRONIN S
DAN ME
MOHAMED A
HUSSEIN M
SENSENBRENNER LL
Citation: V. Ratanatharathorn et al., BUSULFAN-BASED REGIMENS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION INPATIENTS WITH MYELODYSPLASTIC SYNDROMES, Blood, 81(8), 1993, pp. 2194-2199
Risultati:
1-17
|